MENU
ITRMF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Iterum Therapeutics (ITRMF) Ownership - Who owns Iterum Therapeutics?

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
532
P/E Ratio
9.53
Total Cash
11M
Projected Growth
N/A
Total Debt
33.74M
Revenue
390K
Risk (Beta)
6.82
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Who owns Iterum Therapeutics? ITRMF symbol Ownership - Tickeron.com